Objective: To determine the extent and nature of delayed presentation of patients treated for breast cancer at Kenyatta National Hospital (KNH).Setting: Kenyatta National Hospital (KNH) which is a tertiary, teaching and referral hospital in Nairobi, Kenya. Results: A total of 166 patients were recruited into the study. The mean age was 47 years with a range between 17 and 88 years. Females constituted 98.8%, had an average of 4.5 children per subject with a median of 4 and a range of 0-11. A lump as the first noticed symptom present in 87.3% and 52.1% were pre-menopausal. Only 11 (6.62%) patients presented within 30 days of discovering their breast symptom, 34 (20.4%) presented between thirty and ninety days and the remaining 115 (73.1%) ...
Africa has low breast cancer incidence rates but high mortality rates from this disease due to poor ...
Background. Breast cancer is the most common cancer in women in many low- and middle-income countrie...
Background: The most important prognostic factor in head and neck cancer is the stage of the disease...
Objective: To determine the extent and nature of provider delay in breast cancer management at Kenya...
Objective: To determine the extent and nature of provider delay in breast cancer management at Kenya...
PURPOSE: Africa has low breast cancer incidence rates but high mortality rates from this disease due...
Africa has low breast cancer incidence rates but high mortality rates from this disease due to poor ...
Objective: To identify factors related to women's delay in presenting with breast cancer symptoms to...
To assess the delays and define the causes of delay in presentation and treatment of breast cancer p...
Aims—To assess patient delay differences between early and late stage breast cancer among women in U...
The global burden and threat of non-communicable diseases constitute one of the major challenges for...
Background. Breast cancer is the most common cancer in women in many low- and middle-income countrie...
Objectives: To determine the causes of delayed presentation in breast cancer patients at Korle Bu Te...
Background: There is evidence to show that delays in breast cancer management are detrimental to pat...
Purpose: Patients with breast cancer (BC) in Area 2 KwaZulu-Natal, South Africa, often present with ...
Africa has low breast cancer incidence rates but high mortality rates from this disease due to poor ...
Background. Breast cancer is the most common cancer in women in many low- and middle-income countrie...
Background: The most important prognostic factor in head and neck cancer is the stage of the disease...
Objective: To determine the extent and nature of provider delay in breast cancer management at Kenya...
Objective: To determine the extent and nature of provider delay in breast cancer management at Kenya...
PURPOSE: Africa has low breast cancer incidence rates but high mortality rates from this disease due...
Africa has low breast cancer incidence rates but high mortality rates from this disease due to poor ...
Objective: To identify factors related to women's delay in presenting with breast cancer symptoms to...
To assess the delays and define the causes of delay in presentation and treatment of breast cancer p...
Aims—To assess patient delay differences between early and late stage breast cancer among women in U...
The global burden and threat of non-communicable diseases constitute one of the major challenges for...
Background. Breast cancer is the most common cancer in women in many low- and middle-income countrie...
Objectives: To determine the causes of delayed presentation in breast cancer patients at Korle Bu Te...
Background: There is evidence to show that delays in breast cancer management are detrimental to pat...
Purpose: Patients with breast cancer (BC) in Area 2 KwaZulu-Natal, South Africa, often present with ...
Africa has low breast cancer incidence rates but high mortality rates from this disease due to poor ...
Background. Breast cancer is the most common cancer in women in many low- and middle-income countrie...
Background: The most important prognostic factor in head and neck cancer is the stage of the disease...